Mascoma Wealth Management’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-328
Closed -$8.38K 508
2023
Q1
$8.38K Hold
328
﹤0.01% 426
2022
Q4
$6.08K Hold
328
﹤0.01% 465
2022
Q3
$5K Hold
328
﹤0.01% 470
2022
Q2
$8K Hold
328
﹤0.01% 441
2022
Q1
$12K Buy
+328
New +$16.1K ﹤0.01% 415

Other funds holding CRNC

Mascoma Wealth Management's CRNC Position: Q2 2023 in Review

Mascoma Wealth Management sold out of Cerence (CRNC) in Q2 2023, closing a stake of 328 shares — an estimated $8.38K sold.

Mascoma Wealth Management first reported a position in CRNC in Q1 2022 and held it in 5 quarters. The position peaked at $12K in Q1 2022. 227 funds tracked by Wall St. Rank hold CRNC as of Q2 2023.

  • Mascoma Wealth Management reported no remaining Cerence position as of Q2 2023 after selling out during the quarter.
  • Mascoma Wealth Management sold 328 Cerence shares in Q2 2023, an estimated $8.38K.
  • Mascoma Wealth Management first reported a position in Cerence in Q1 2022 and held it in 5 quarters.
  • Mascoma Wealth Management's Cerence position peaked at $12K in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Cerence as of Q2 2023.

Based on Mascoma Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.